Evidence map›Paper›PMID 30870248›Full record

ReviewCurrent opinion in hematology2019

A somatic missense mutation in GNAQ causes capillary malformation.

Colette Bichsel, Joyce Bischoff

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. PIPProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Targeted Therapies for Slow-Flow Vascular Malformations.The Australasian journal of dermatology · 2025
    Review
  8. EndothelialFrontiers in cell and developmental biology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. ISSVA Classification of Vascular Anomalies and Molecular Biology.International journal of molecular sciences · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Article
  20. PIPProceedings of the National Academy of Sciences of the United States of America · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Colette BichselDepartment of Surgery, Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Joyce Bischoff
Harvard University · US

Funding

Capillary malformation: From somatic GNAQ mutations to disrupted endothelial biologyR01HL127030 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI BISCHOFF, JOYCE E., GREENE, ARIN K. · 2016 to 2023
$5.2M
NHLBI NIH HHS R01 HL127030
6 · The paper itself

Abstract

purpose of reviewCapillary malformations, the most common type of vascular malformation, are caused by a somatic mosaic mutation in GNAQ, which encodes the Gαq subunit of heterotrimeric G-proteins. How the single amino acid change - predicted to activate Gαq - causes capillary malformations is not known but recent advances are helping to unravel the mechanisms. RECENT

findingsThe GNAQ R183Q mutation is present not only in endothelial cells isolated from skin and brain capillary malformations but also in brain tissue underlying the capillary malformation, raising questions about the origin of capillary malformation-causing cells. Insights from computational analyses shed light on the mechanisms of constitutive activation and new basic science shows Gαq plays roles in sensing shear stress and in regulating cerebral blood flow. SUMMARY: Several studies confirm the GNAQ R183Q mutation in 90% of nonsyndromic and Sturge-Weber syndrome (SWS) capillary malformations. The mutation is enriched in endothelial cells and blood vessels isolated from skin, brain, and choroidal capillary malformations, but whether the mutation resides in other cell types must be determined. Further, the mechanisms by which the R183Q mutation alters microvascular architecture and blood flow must be uncovered to develop new treatment strategies for SWS in particular, a devastating disease for which there is no cure.

Indexed as

CapillariesGTP-Binding Protein alpha Subunits, Gq-G11Mutation, MissenseNeoplasm ProteinsSturge-Weber SyndromeVascular MalformationsAmino Acid SubstitutionAnimalsHumansGNAQ protein, humanGTP-Binding Protein alpha Subunits, Gq-G11Neoplasm Proteins

Identifiers

PMID30870248
PMCPMC8142900
OpenAlexW2922408978

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.